GLS and neoplasm: According to the tumor heterogeneity analysis, we found that GLS expression was most negatively correlated with TMB in CHOL (r = -0.51) (Fig. 18A), which indicated that down-regulated GLS might serve as a breakthrough for enhancing immunotherapy in CHOL.